Yoshihisa et al. found that circulating soluble CD10 might predict prognosis in HF patients with reduced ejection fraction (HFrEF) by degrading vasodilator peptides such as NPs (Yoshihisa et al., 2019b). Here, MME is linked to hydrops fetalis.